HBV Cure Workshop 2018
Pietro Scalfaro, Chief Medical Officer of ENYO Pharma, has participated to the 5th edition of the International HBV Cure Workshop 2018 on November 7 -8 in Toronto, Canada. The HBV Cure Workshop is a scientific platform that allows to accelerate the research in finding a cure of hepatitis B. During this event, researchers and clinical experts had the opportunity to discuss current challenges regarding the disease and to present research outcomes.
Read next in 'Latest news'
- Orphan Drug Designation (ODD) granted to Vonafexor for Alport syndrome by both the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA)
- New publication: Hepatic and renal improvements with FXR agonist Vonafexor in individuals with suspected fibrotic NASH
- New publication : An anti-diabetic drug targets NEET (CISD) proteins through destabilization of their [2Fe-2S] clusters
- Swiss NASH Foundation sponsorship
- ENYO Pharma in the Top 50 of the EIC ScalingUp List